# A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation

> **NCT00646763** · PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 35 (actual)

## Conditions studied

- Cytokines

## Interventions

- **DRUG:** G-CSF, GM-CSF administered at extremities
- **DRUG:** G-CSF and GMCSF administered at abdomen

## Key facts

- **NCT ID:** NCT00646763
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2009-09
- **Final completion:** 2011-02
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Accrual goal met
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646763, "A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00646763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*